Quick Answer
UNITED THERAPEUTICS Corp reported Net Income of $1.33 billion for fiscal year 2025.
UNITED THERAPEUTICS Corp Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $1.33B | +11.7% |
| 2024 | $1.20B | +21.4% |
| 2023 | $984.80M | +35.4% |
| 2022 | $727.30M | +52.9% |
| 2021 | $475.80M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $338.70M | +9.6% | +9.4% |
| June 30, 2025 | $309.50M | +11.3% | -3.9% |
| March 31, 2025 | $322.20M | +5.1% | +4.2% |
| September 30, 2024 | $309.10M | +15.5% | +11.1% |
| June 30, 2024 | $278.10M | +7.3% | -9.3% |
| March 31, 2024 | $306.60M | +27.3% | +14.6% |
| September 30, 2023 | $267.60M | +11.8% | +3.2% |
| June 30, 2023 | $259.20M | +123.4% | +7.6% |
- UNITED THERAPEUTICS Corp showed an increase of +11.7% in Net Income compared to the prior fiscal year.
- Over the 2021–2025 period, UNITED THERAPEUTICS Corp’s net income has grown by 180.5% (from $475.80 million to $1.33 billion).
- The most recent figure is from UNITED THERAPEUTICS Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: